Atlas FDA

QNL

5 FDA 510(k) clearances · Product code

211 daysmedian time to decision
297 days90th percentile
5clearances measured

FDA profile

Official device name
Medium-Term Adjunctive Predictive Cardiovascular Indicator
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2210
Medical specialty
Cardiovascular
FDA definition
The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
eCARTv5 Clinical Deterioration Suite (“eCART”) (K233253)Agilemd, Inc.2024-06-21
CLEWICU System (K233216)Clew Medical , Ltd.2024-01-13
SignalHF (IM008) (K230842)Implicity, Inc.2023-10-25
Global Hypoperfusion Index (GHI) Algorithm (K231038)Edwards Lifesciences, LLC2023-07-26
CLEWICU System (ClewICUServer and ClewICUnitor) (K200717)Clew Medical , Ltd.2021-01-09

Track QNL automatically

Every clearance here is in the API, with alerts when new ones post.